As of July 2002 Carisoprodol is considered to be a schedule CIV by the State of Florida. A state bill was passed due to a recent understanding that the drug is becoming more widely abused. Possession of the drug without a valid prescription in the state of Florida is now a third degree felony. The rest of the United State falls under the DEA scheduling for the drug, which considers carisoprodol a non-schedule chemical.
As of November 2008 Carisoprodol (Somadril, Somadril comp.) has been taken off the market in Sweden due to problems with dependence, abuse and side effects. The agency overseeing pharmaceuticals has considered other drugs used with the same indications as carisoprodol to have the same or better effects without the risks of the drug.[1] In the EU, the European Medicines Agency has issued a release recommending that member states suspend marketing authorization for this product.